United States · FDA National Drug Code directory
Alvimopan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0591-2312_ef9ffdef-f019-4329-b6a4-658fa872d3b8
- Product NDC
- 0591-2312
- Form
- CAPSULE
- Composition / generic term
- Alvimopan
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201201
- Source listing expiry
- 20261231
Source-listed ingredients
- ALVIMOPAN — 12 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 BLISTER PACK in 1 CARTON (0591-2312-15) / 1 CAPSULE in 1 BLISTER PACK (0591-2312-45) · 0591-2312-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →